Search
Seres Therapeutics Inc
MCRBAdd to Watchlist
7.740USD
-0.200-2.52%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
67.84MMarket Cap
LossP/E TTM
Seres Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
789.00K
--
EPS(YoY)
0.64
3553.18%
Analyst Rating
BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its current assets were 49.38M, with a year-on-year change of 27.67.
What are the total assets of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its total assets of Seres Therapeutics Inc were 138.19M, with a year-on-year change of -1.16.
What are the total liabilities of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its total liabilities of Seres Therapeutics Inc were 93.97M, with a year-on-year change of -25.43.
What is the total equity of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its total equity of Seres Therapeutics Inc was 44.22M, with a year-on-year change of 220.79.
What is the net investment of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its net investment of Seres Therapeutics Inc was -42.00K, with a year-on-year change of -100.03.
What is the net financing of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its net financing of Seres Therapeutics Inc was 13.90M, with a year-on-year change of 115.38.
What is the Earnings Per Share (EPS) of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.64, with a year-on-year change of 3553.18.
What is the Return on Assets (ROA) of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 4.10, with a year-on-year change of 108.12.
What is the operating profit of Seres Therapeutics Inc?
According to Seres Therapeutics Inc's FY2025 earnings report, its operating profit was -92.94M, with a year-on-year change of 19.40.